Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Superficial Vein Therapies

This will play a video. - Five clinicians sit in discussion at a table

Superficial vein therapies

Help your patients find relief from chronic venous insufficiency.
Explore Products
Alert Indications, safety, and warnings

Chronic venous insufficiency

Venous reflux is a progressive condition that, left untreated, can lead to chronic venous insufficiency (CVI).

More on CVI

VenaSeal™ closure system

Reach new lengths. Treat more diseased vein — maximize your impact. The VenaSeal™ closure system delivers immediate and lasting vein closure with its proprietary medical adhesive formula, with a demonstrated 94.6% closure rate at 5 years.1-5

Learn more

ClosureFast™ procedure

The ClosureFast™ procedure, with its patented overlap design, is the only RFA procedure with published clinical data demonstrating long-term safety and efficacy, with a 91.9% closure rate at 5 years.4,5

View procedure

Clinical evidence

See clinical evidence for our superficial vein therapy products.

See evidence
Team of Doctors sitting in front of computer attending webinar

Resources and support

Find product, condition, and patient education materials.

Find resources

Connect with us

Connect with a Medtronic representative and sign up for ongoing updates.

Contact us

Explore products

Learn more about our superficial vein products.

See Products
VenaSeal closure system components on white background
ClosureFast radiofrequency ablation system on white background

References

1

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. April 2015;61(4):985-994.

2

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. March 2021;9(2):329-334.

3

Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. April 2017;25(2):149-156.

4

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. September 2017;5(5):658-666.

5

Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. November 2020;8(6):978-989.